SEC Form 4 research
| Issuer | Retension Pharmaceuticals, Inc. |
|---|---|
| Tickers | RTSN |
| Reporting owners | 10 |
| Officers and directors | 1 |
| Last public filing | 2026-10-13 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-13 | 2026-10-13 | Keller Eric L. | P | 20,800 | $12 | Not reported |
| 2026-10-13 | 2026-10-13 | Keller Eric L. | A | 255,174 | $0 | Not reported |
| 2026-10-13 | 2026-10-13 | Cheruvu Pavan | A | 5,636 | $0 | Not reported |
| 2026-10-13 | 2026-10-13 | BERGER FRANKLIN M | P | 10,000 | $12 | Not reported |
| 2026-10-08 | 2026-10-08 | BERENDT MICHAEL J | A | 5,636 | $0 | Not reported |
| 2026-10-08 | 2026-10-08 | Olds Donald | A | 5,636 | $0 | Not reported |
| 2026-10-08 | 2026-10-08 | BERGER FRANKLIN M | A | 5,636 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.